Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 6303.192678 | Peak area normalized | male | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 6610.30652 | Peak area normalized | male | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 7338.053764 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 7646.010588 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 8552.627229 | Peak area normalized | male | pre-diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 9118.055895 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 9131.44241 | Peak area normalized | male | pre-diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 11242.53819 | Peak area normalized | female | normoglycemic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 12731.15181 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 14975.70957 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 25233.15775 | Peak area normalized | female | diabetic | Neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 25237.9998 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 31155.50925 | Peak area normalized | female | diabetic | no neuropathy |
C18 NEGATIVE ION MODE | N-(octadecanoyl)-sphing-4-enine; [M-H]-@7.44 | 42607.47894 | Peak area normalized | female | normoglycemic | Neuropathy |